Navigation Links
Tumbling E Pad(100 sheets) BCE

ProductsTumbling E Pad(100 sheets) BCE
Company Bernell
Item Tumbling E Pad(100 sheets) BCE
Features 
Description Printed with large 20/200 E on one side and a series of five 20/20 tumbling Es on the other- calibrated to a 20 ft. distance. May be used to test and train peripheral awareness.
Info Bernell
Customer Service: (800) 348-2225
Web site: http://www.bernell.com/

Related medicine products :

1. Tumbling E/20 Distance Chart
2. Near PT Test Card/Tumbling E
The new Nellcor N-45 Handheld Pulse Oximeter is compatible with our complete line of OxiMax Pulse Oximetry Sensors, so clinicians have the convenience of Nellcors most advanced sensor technology in a
...or's most popular handheld oximeter has been conve... and is now compatible with the entire line of inn...ehead Sensor and SoftCare Nonadhesive Sensors. The...also incorporates Nellcor's latest advanced signal...
...ellcor N395 Pulse Oximeter with Oxismart XL Advanc...ion conditions, cutting through nonspecific noise ...rate values. , ,The N395 monitor is also equi...ugh in clinician-programmable alarm sensitivity fo...
...e cornerstone of the revolutionary OxiMax® Pul...r combines Nellcor's best-in-class pulse oximetry ... motion-tolerant OxiMax N-595 Pulse Oximeter is eq...ing technology, which enables it to withstand the ...
Medicine Products:
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...unique public-private partnership in healthcare, t...ll ensure medical care for the poor that will be p... The Sarva Swasthya Mission Trust is the brainchi...as roped in major investors to provide funds. He h...
...ia become a "near-epidemic" in the Dooars region o...re than 20,000 persons in the past two and a half ...y.// Nirmal Das, an MLA from Alipurduar constitue...at 48 deaths had been reported from Alipurduar sub...
...n biotech major Biocon Ltd has roped in Bayer Heal...ugen in the Chinese market, the company //said in ...h firm plans to launch Insugen in China by 2007-08...stration trials and seeking the regulatory approva...
...aldomero Olivera said that the ruthless fish-eatin... back pain.// He is planning to present his findi...snails, with their striking patterns and elegant s...tching shells on display and for sale at the annua...
Other Medicine News:Health News:Bayer to Market Biocon Insulin in China 2
(Date:9/4/2008)...tCall/ -- BioForm Medical,Inc. (Nasdaq: BFRM ) t...Polidocanol, conducted in Germany by BioForm Medic...H (Kreussler), successfully met the study primary,...a New Drug Application,(NDA) process., In the piv...safety of,Aethoxysklerol compared to Sodium Tetrad...
(Date:9/4/2008)...ented at ESC Congress-, PHILADELPHIA, Sept. 4 /PR...y, the GISSI Heart Failure (GISSI-HF) study, showe...uced all cause mortality and hospital,admissions f... heart,failure. These findings are published in th...presented at the European Cardiovascular Society (...
(Date:9/4/2008)...outhern Research Institute,today announced that th...,the organization to participate in the newly-fund...work (MLPCN). The MLPCN -- a collaborative,researc...ogram which is,designed to benefit human health, b...d validate future targets for drug discovery., So...
(Date:9/4/2008)...e/ -- Axentis Pharma AG has,initiated a clinical p...ty,of a new therapeutic formulation for the treatm...is patients. The new formulation allows an,establi... the site of,infection. The forthcoming trial will...f the new drug. Initial results are expected in su...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Microchip Biotechnologies Inc Collaborating With Stanford University on Developing a Front End Microfluidic Based Sample Preparation System for Pyro 3591 1Microchip Biotechnologies Inc Collaborating With Stanford University on Developing a Front End Microfluidic Based Sample Preparation System for Pyro 3591 2Vermillion Receives Award From the Society of Gynecologic Oncologists 1441 1Vermillion Receives Award From the Society of Gynecologic Oncologists 1441 2Vermillion Receives Award From the Society of Gynecologic Oncologists 1441 3Vermillion Receives Award From the Society of Gynecologic Oncologists 1441 4Natures helpers 3A Using microorganisms to remove TCE from water 12998 1Natures helpers 3A Using microorganisms to remove TCE from water 12998 2Natures helpers 3A Using microorganisms to remove TCE from water 12998 3The Female Health Company Receives USAID DELIVER PROJECT Order for 6 1 Million Units 12995 1The Female Health Company Receives USAID DELIVER PROJECT Order for 6 1 Million Units 12995 2
... and Regulatory Development of Oral,Anti-Inflammat...ire-FirstCall/ -- Celgene,Corporation announced it... anti-inflammatory candidates across a broad range...an oral TNF,antagonist and anti-inflammatory agent...llent side effect profile in a placebo,controlled ...
...2007 /PRNewswire/ -- NanoBio,Corporation, a biopha...the treatment and prevention of serious infections...ase 1 clinical study of,NB-002, the company,s drug...or the topical treatment of onychomycosis. , The P...7 and,involved 20 subjects who received twice-dail...
Other Medicine Technology:Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 2Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 3Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 4NanoBio Corporation Announces Positive Phase 1 Clinical Results for,Topical Treatment for Onychomycosis 2NanoBio Corporation Announces Positive Phase 1 Clinical Results for,Topical Treatment for Onychomycosis 3